Cytogenetic changes and their prognostic significance in elderly acute myeloid leukemia;Zmiany cytogenetyczne i ich znaczenie rokownicze w ostrej białaczce szpikowej u starszych osób

Polskie Archiwum Medycyny Wewnetrznej

Volumn 109, Issue 6, 2003, Pages 571-577

  Haus, Olga ^a,b   Kotlarek Haus, Sabina ^c   Duszeńko, Ewa ^a   Makowska, Izabela ^a   Potoczek, Stanisław ^a   Nowak, Elzbieta ^a   Jaźwiec, Bozena ^a   Kuliczkowski, Kazimierz ^a  

^a Katedra i Klinika Hematologii   (Poland)

^b UMK   (Poland)

^c AM   (Poland)

Author keywords

Elderly acute myeloid leukemia; Karyotype; Prognostic significance

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CYTOGENETICS; DISEASE COURSE; ELDERLY CARE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; KARYOTYPE; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; POLAND; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0038783345     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Baudard M., Marie J.P., Cadiou M., Viguie P., Zittoun R.: Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients. Brit. J. Haematol., 1994, 86, 82.
2. Harousseau J.L.: Acute myeloid leukemia in the elderly. Blood Reviews., 1998, 12, 145.
3. Leith C.P., Kopecky K.J., Godwin J. i wsp.: Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologie subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood, 1997, 89, 3323.
4. Head D.R.: Revised classification of acute myeloid leukemia. Leukemia, 1996, 10, 1826.
5. Grimwade D., Walker H., Oliver F. i wsp.: The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. Blood, 1998, 32, 2322.
6. Grimwade D., Walker H., Harrison G. i wsp.: The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML 11 trial. Blood, 2001, 98, 1312.
7. Haferlach T: More individual markers are necessary for patients with acute myeloid leukemia (AML). Does cytomorphology or cytogenetics define the biological entity? Leukemia, 1996, 10, (suppl. 3), 55.
8. Goldstone A.H., Burnett A.K., Wheatley, K., Smith A.G., Hutchinson R.M., Clark R.E.: Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML 11 trial. Blood, 2001, 98, 1302.
9. Mrózek K., Heinonen K., de la Chapelle A., Bloomfield C.D.: Clinical significance of cytogenetics in acute myeloid leukemia. Semin. Oncol., 1997, 24, 17.
10. Slovak M.L., Kopecky K.J., Cassileth P.A. i wsp.: Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/ Eastern Cooperative Oncology Group Study. Blood, 2000, 96, 4075.
11. Haus O., Czarnecka M., Kotlarek-Haus S., Kuliczkowski K., Duszeńko E., Makowska I.: Chromosome aberrations in primary and secondary acute myeloblastic leukemia (AML). [w:] Acute Leukemias VIII. Prognostic Factors and Treatment Strategies. (red.) T. Buchner, W. Hiddemann, B. Wormann, G. Schellong, J. Ritter, U. Creutzig. Wyd.: Springer Verlag, Berlin, Heidelberg, New York, 2001, 49-53.
12. ISCN (1995) An International System for Human Cytogenetic Nomenclature. (red.) F. Mitelman, Wyd.: S. Karger, Basel, 1995.
13. Schoch C., Haferlach T., Haase T. i wsp.: Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment. Brit. J. Haematol., 2001, 112, 118.
14. Visani G., Bernasconi B., Boni M. i wsp.: The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients. Leukemia, 2001, 15, 903.
15. Rossi G., Pelizzari A.M., Bellotti D., Tonelli M., Barlati S.: Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Leukemia, 2001, 14, 636.
16. Mauritzson N., Johansson B., Albin M. i wsp.: A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender. Eur. J. Haematol., 1999, 62, 95.
17. Stirewalt D.L., Kopecky K.J., Meshinchi S. i wsp.: FLT3, RAS and TP53 mutations in elderly patients with acute myeloid leukemia. Blood, 2001, 97, 3589.
18. Harris N.L., Jaffe E.S., Diebold J. i wsp.: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Yirginia, November, 1997. J. Clin. Oncol., 1999, 17, 3835.